Retrospective Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Oct 16, 2022; 10(29): 10451-10466
Published online Oct 16, 2022. doi: 10.12998/wjcc.v10.i29.10451
Table 2 Comparison of general characteristics of patients with different differentiated types of gastric cancer
Variable
Differentiated (%), n = 1550
P value
SRC (%), n = 1326
P value
Undifferentiated (%), n = 2324
Age (yr)
< 4013 (0.84)< 0.001110 (8.30)< 0.00177 (3.31)
40-60241 (15.55)< 0.001518 (39.06)< 0.001630 (27.11)
60-80920 (59.35)< 0.001583 (43.97)< 0.0011187 (51.08)
> 80376 (24.26)< 0.001115 (8.67)< 0.001430 (18.50)
Sex< 0.001< 0.001
Male959 (61.87)625 (47.13)1349 (58.05)
Female591 (38.13)701 (52.87)975 (41.95)
Race
White804 (51.87)< 0.001819 (61.74)0.0051324 (56.97)
Black295 (19.03)0.001188 (14.19)0.536347 (14.93)
Black-AI16 (1.03)0.89013 (0.98)0.97823 (0.99)
Black-API435 (28.07)0.002306 (23.09)0.007630 (27.11)
T stage
T1a281 (18.13)0.004187 (14.10)< 0.001129 (5.56)
T1b325 (20.97)< 0.001126 (9.51)0.140257 (11.06)
T2242 (15.61)0.002155 (11.69)0.355296 (12.74)
T3450 (29.03)0.930383 (28.89)< 0.001864 (37.17)
T4a171 (11.03)< 0.001385 (29.03)0.033599 (25.77)
T4b81 (5.23)0.07890 (6.78)0.309179 (7.70)
N stage
N0946 (61.03)< 0.001512 (38.61)0.001775 (33.35)
N1278 (17.94)0.097207 (15.61)0.001466 (20.05)
N2181 (11.68)0.010198 (14.93)< 0.001476 (20.48)
N3145 (9.35)< 0.001409 (30.85)0.002607 (26.12)
AJCC stage
I730 (47.10)< 0.001372 (28.05)< 0.001478 (20.57)
II452 (29.16)< 0.001305 (23.00)< 0.001692 (29.78)
III368 (23.74)< 0.001649 (48.95)0.6791154 (49.65)
Primary site
Fundus67 (4.32)0.08441 (3.09)0.66578 (3.36)
Body198 (12.77)0.527180 (13.58)0.898319 (13.73)
Antrum640 (41.29)< 0.001434 (32.73)0.061832 (35.80)
Pylorus85 (5.48)0.87971 (5.36)0.687132 (5.68)
Lesser curve228 (14.71)0.694202 (15.23)0.452376 (16.18)
Lesser curve-Greater curve85 (5.48)0.29485 (6.41)0.218126 (5.42)
Lesser curve-Overlapping/NOS247 (15.95)< 0.001313 (23.60)0.007461 (19.83)
Radiotherapy< 0.0010.410
Yes304 (19.61)415 (31.30)697 (29.99)
No1246 (80.39)911 (68.70)1627 (70.01)
Chemotherapy< 0.0010.015
Yes535 (34.52)785 (59.20)1279 (55.03)
No1015 (65.48)541 (40.80)1045 (44.97)
Tumor size (cm)
< 2354 (22.84)< 0.001212 (15.99)< 0.001254 (10.93)
2-5674 (43.48)0.008512 (38.61)0.0041012 (43.55)
> 5420 (27.10)0.017413 (31.15)< 0.001867 (37.31)
NA102 (6.58)< 0.001189 (14.25)< 0.001191 (8.21)